FDA Panel Weighs Antipsychotic Drug Use In Kids

Reuters -- U.S. advisers began considering on Tuesday whether the makers of three blockbuster antipsychotic drugs should be allowed to promote them for children and teens with schizophrenia or bipolar disorder.